Join
Live feed
·
INSIDERFilingvia Quantisnow
Spero Therapeutics Inc. logo

Officer Rajavelu Esther was granted 249,000 shares and sold $40,572 worth of shares (18,442 units at $2.20), increasing direct ownership by 27% to 1,100,008 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRO (Spero Therapeutics Inc.) and more on Quantisnow.